Strongbridge Biopharma Plc Net Income per Employee (SBBP), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Strongbridge Biopharma plc  (NASDAQ: SBBP)
 

Strongbridge Biopharma Plc Net Income per Employee

SBBP's Quarterly Results, Trends, Rankings, Statistics
Strongbridge Biopharma Plc recorded a cumulative net loss of $-40 million during 12 month ending in the second quarter 2021.
The Healthcare sector has seen employees of 165 other companies achieving higher income per employee. While Strongbridge Biopharma Plc's total ranking has deteriorated compared to the previous quarter from 0 to 3729.


What is Income per Employee Ratio?






SBBP Net Income per Employee (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -257,436 -283,276 -288,942 -269,929 -338,077
SBBP's Total Ranking # 3729 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


SBBP Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 166
Healthcare Sector # 491
Overall Market # 3729

Net Income per Employee Statistics
High Average Low
$ 279,385 $ -292,428 $ -727,455
(Sep 30 2019)   (Dec 31 2017)







Companies with similar Income per Employee for 12 month ending Jun 30 2021, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2021Number of Employees Jun 30 2021


Date modified: 2026-08-31T17:15:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.